<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027145" disease_type="Disease or Syndrome" abbrv="">Myxedema</z:e> crisis is a severe life threatening form of decompensated <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo> which is associated with a high mortality rate </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infections</z:e> and discontinuation of thyroid supplements are the major precipitating factors while <z:hpo ids='HP_0002045'>hypothermia</z:hpo> may not play a major role in tropical countries </plain></SENT>
<SENT sid="2" pm="."><plain>Low intracellular T3 leads to cardiogenic shock, respiratory <z:hpo ids='HP_0000716'>depression</z:hpo>, <z:hpo ids='HP_0002045'>hypothermia</z:hpo> and <z:hpo ids='HP_0001259'>coma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients are identified on the basis of a low index of suspicion with a careful history and examination focused on features of <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo> and precipitating factors </plain></SENT>
<SENT sid="4" pm="."><plain>Arrythmias and <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorders</z:e> are increasingly being identified in <z:e sem="disease" ids="C0027145" disease_type="Disease or Syndrome" abbrv="">myxedema</z:e> crisis </plain></SENT>
<SENT sid="5" pm="."><plain>Thyroid replacement should be initiated as early as possible with careful attention to <z:hpo ids='HP_0002615'>hypotension</z:hpo>, fluid replacement and steroid replacement in an intensive care facility </plain></SENT>
<SENT sid="6" pm="."><plain>Studies have shown that replacement of thyroid hormone through ryles tube with a loading dose and maintenance therapy is as efficacious as intravenous therapy </plain></SENT>
<SENT sid="7" pm="."><plain>In many countries T3 is not available and oral therapy with T4 can be used effectively without major significant difference in outcomes </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002615'>Hypotension</z:hpo>, <z:hpo ids='HP_0001662'>bradycardia</z:hpo> at presentation, need for mechanical ventilation, <z:hpo ids='HP_0002045'>hypothermia</z:hpo> unresponsive to treatment, <z:hpo ids='HP_0100806'>sepsis</z:hpo>, intake of <z:chebi fb="4" ids="35717">sedative drugs</z:chebi>, lower GCS and high APACHE II scores and Sequential Organ Failure Assessment (SOFA) scores more than 6 are significant predictors of mortality in <z:e sem="disease" ids="C0027145" disease_type="Disease or Syndrome" abbrv="">myxedema</z:e> crisis </plain></SENT>
<SENT sid="9" pm="."><plain>Early intervention in <z:e sem="disease" ids="C0020676" disease_type="Disease or Syndrome" abbrv="">hypothyroid</z:e> patients developing <z:hpo ids='HP_0100806'>sepsis</z:hpo> and other precipitating factors and ensuring continued intake of thyroid supplements may prevent mortality and morbidity associated with <z:e sem="disease" ids="C0027145" disease_type="Disease or Syndrome" abbrv="">myxedema</z:e> crisis </plain></SENT>
</text></document>